Amgen (Switzerland) - Concepedia

Concepedia

Institution (Company)

Amgen (Switzerland)

Homepage Wikipedia ROR

Also Known As

Amgen (Switzerland), Applied Molecular Genetics

1.1K

Publications

35.1K

Citations

74

Authors

278

Concepts

About

Amgen (Switzerland) is a company institution in Zug, Switzerland known for medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	15	31	901
2	Engineering	5	10	356
3	Arts	1	1	13
4	Business	1	1	17
5	Language Studies	1	1	31

Amgen (Switzerland)

×

1.1K

Publications

35.1K

Citations

	Year	Citations
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis Paolo Raggi, Glenn M. Chertow, P. U. Torres, Nephrology Dialysis Transplantation	2010	548
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières, The Lancet Non-small-cell Lung CancerMedicinePathologyCancer TreatmentCancer Genetics	2023	507
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population J. Floege, Jae Bum Kim, Elizabeth Ireland, Nephrology Dialysis Transplantation	2010	468
Multiple myeloma: patient outcomes in real‐world practice Kwee Yong, Michel Delforge, Christoph Driessen, British Journal of Haematology	2016	311
An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab) Gregor Verhoef, Hans Erik Johnsen, Francesca Gaia Rossi, Blood	2008	233
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT) Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington, Annals of Oncology	2018	204
Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia Laurent Bastit, A. Vandebroek, Sevilay Altıntaş, Journal of Clinical Oncology	2008	194
Development and validation of a predictive mortality risk score from a European hemodialysis cohort Jürgen Floege, Iain Gillespie, Florian Kronenberg, Kidney International	2015	182
Mutations in CABP4, the Gene Encoding the Ca2+-Binding Protein 4, Cause Autosomal Recessive Night Blindness Christina Zeitz, Barbara Kloeckener‐Gruissem, U. Förster, The American Journal of Human Genetics Ocular DiseaseSignal TransductionRetinaOphthalmologyPhotoreceptor Cell	2006	179
Analysis of <i>KRAS</i> / <i>NRAS</i> Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer Marc Peeters, Kelly S. Oliner, Timothy Price, Clinical Cancer Research	2015	179

Page 1